Mercer Global Advisors
KURA icon

Mercer Global Advisors’s Kura Oncology KURA Stock Holding History

Mercer Global Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$873K Buy
79,588
+43,556
+121% +$411K ﹤0.01% 1847
2026
Q1 		$293K Sell
36,032
-14,048
-28% -$121K ﹤0.01% 2463
2025
Q4 		$520K Buy
50,080
+17,197
+52% +$180K ﹤0.01% 1831
2025
Q3 		$291K Buy
+32,883
New +$234K ﹤0.01% 2111

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Mercer Global Advisors's KURA Position: Q2 2026 in Review

Mercer Global Advisors increased its Kura Oncology (KURA) stake by 121% in Q2 2026, buying an estimated $411K and bringing the position to 79,588 shares worth $873K. The position accounts for ﹤0.01% of the portfolio, ranked #1847.

Mercer Global Advisors first reported a position in KURA in Q3 2025 and has held it in 4 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Mercer Global Advisors held 79,588 shares of Kura Oncology worth $873K as of Q2 2026.
  • Mercer Global Advisors bought 43,556 Kura Oncology shares in Q2 2026, an estimated $411K.
  • Kura Oncology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1847 holding.
  • Mercer Global Advisors first reported a position in Kura Oncology in Q3 2025 and has held it in 4 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.